Indefinite Delivery Contract SPE2DX15D9987

DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a single-award Indefinite Delivery Contract (SPE2DX) by the Defense Logistics Agency's Medical Supply Chain division on July 8, 2025, with a contract ceiling of $4,999,999.00 and an ultimate completion date of December 31, 2026. The contract provides firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities nationwide. All work is performed at the contractor's Park Ridge, Illinois location. No small business set-asides were applied to this contract, allowing DMS Pharmaceutical Group to compete as a woman-owned small business entity in the federal pharmaceutical procurement market.

The contract encompasses delivery orders for branded and generic prescription medications, injectable pharmaceuticals, tablets, and specialty medical supplies including antibiotics (Gentamicin, Primaxin, Sulfamethoxazole-Trimethoprim), corticosteroids (Dexamethasone), antimalarial agents (Coartem tablets), psychotropic medications (Sertraline), and miscellaneous pharmaceutical products. The twenty task orders issued between July 1 and August 29, 2025, range in individual ceiling values from one dollar to two hundred thirty-six dollars, collectively totaling approximately $2,843.00 in documented delivery orders to date. These orders reflect the contract's operational purpose of providing rapid-response pharmaceutical supply to military health facilities, with completion dates ranging from early July through late August 2025, demonstrating the time-sensitive nature of medical supply chain fulfillment under this indefinite delivery vehicle.